The project combined proteomic, lipidomic, and metabolomic analyses of 174 knockout yeast strains using a high-throughput mass spectrometry workflow.
The company believes its phosphotyrosine enrichment reagents will enable deeper phosphoproteomic studies and aid in drug and diagnostics development.
ImmunArray will use Quanterix's Simoa single-molecule array technology for biomarker analysis, with the potential to enrich its diagnostic panels.
Bruker said the new agreement would allow it to develop the platform for use in pathology labs, including building clinically validated content libraries.
C4BPA could prove useful as a diagnostic biomarker for early stage pancreatic cancer and to help differentiate the disease from other cancers.
In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.
A BMJ study says that about half of former hematology-oncology regulators now work for industry.
Science should wish PhDs who leave academia well, a Nature editorial says.
New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.